Author

A. Qu

Observed name: Angela X. Qu

Institution: PAREXEL International (United States)

Observed institution: PAREXEL International (United States)

OpenAlex ID: A5055408166

Regulatory, Translational, and Operational Considerations for the Incorporation of Biomarkers in Drug Development

2025 · Heather Hatcher, Simona Stankeviciute, et al. · Therapeutic Innovation & Regulatory Science · 10

WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June – 2 July 2021

2022 · Meenu Wadhwa, Hye-Na Kang, et al. · Biologicals · 7

PO-1340 Phase Ⅰ Trail of Concurrent Nab-paclitaxel and Cisplatin with VMAT for LACC

2022 · P. Jiang, A. Qu, et al. · Radiotherapy and Oncology

Works count: 3

Citation count: 17

H-index: 2

I10-index: 1